Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.57 |
| ▸ | LPL | P06858 | 12/20 | 0.57 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | P4HB | P07237 | 1/20 | 0.37 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10021062 | 1.00 | LIPG (0.57) | LIPGLPLCRHBPCRHR2KEAP1 | |
| SCHEMBL27267540 | 0.96 | LIPG (0.55) | LIPGLPLCRHBPCRHR2KEAP1 | |
| SCHEMBL13335834 | 0.89 | LIPG (0.51) | LIPGLPLCRHBPCRHR2KEAP1 | |
| SCHEMBL9611901 | 0.87 | LIPG (0.56) | LIPGLPLCRHBPCRHR2KEAP1 | |
| SCHEMBL24654364 | 0.86 | LIPG (0.77) | LIPGLPLKEAP1NFE2L2CA1 | |
| SCHEMBL30009326 | 0.86 | LIPG (0.77) | LIPGLPLKEAP1NFE2L2CA1 | |
| SCHEMBL25255077 | 0.86 | LIPG (0.46) | LIPGLPLCRHBPCRHR2KEAP1 | |
| SCHEMBL23307938 | 0.86 | LIPG (0.48) | LIPGLPLKEAP1NFE2L2CA1 | |
| SCHEMBL190941 | 0.85 | LIPG (0.60) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL31069015 | 0.85 | LIPG (0.60) | LIPGLPLCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250051250-A1 | DIAMANTANE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | TOSOH CORPORATION (JP) | 2025-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051250-A1 | DIAMANTANE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | AOC1, ODC1, DDT | LIPG 3662/4885LPL 3671/4885CRHBP 4831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.